Ovarian Cancer

People who have been confirmed by lab testing to have epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. People who have received 1 or 2 previous treatment regimens for ovarian cancer, including at least one treatment that contained platinum-based chemotherapy. People whose cancer has…

You have a germ cell tumor located outside the brain that contains at least one of these tumor types: yolk sac tumor, embryonal carcinoma, or choriocarcinoma (mixed tumors that also contain mature or immature teratoma may still qualify). For lower-risk patients (note: this group is no longer enrolling as of January…

You have recently been diagnosed for the first time with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed by a tissue sample (biopsy) Your cancer is at an advanced stage (classified as stage IIB through IV) You are female and aged 18 or older Your doctors expect you to live for at least 6…

You have been diagnosed with advanced or relapsed ovarian cancer, primary peritoneal cancer, or fallopian tube cancer that has been confirmed by a tissue sample (biopsy). You are generally well enough to carry out everyday activities with little or no limitation (confirm with trial site for exact fitness level…

You are a woman diagnosed with a specific type of ovarian, peritoneal, or fallopian tube cancer called "high-grade serous." (Cohorts 1–3) Your cancer has stopped responding to platinum-based chemotherapy, and you have had genetic testing done on your BRCA1 and BRCA2 genes before starting the study treatment. (Cohort…

Women aged 18 or older People with a confirmed diagnosis of high-grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer People whose cancer has become resistant to platinum-based chemotherapy in one of these ways: those who had one course of platinum treatment, responded to it, but saw the…

You are a woman who has been confirmed to carry a specific harmful gene mutation in one of these genes: BRCA1, BRCA2, RAD51C, RAD51D, or BRIP1, tested at one of the participating medical centres Your age falls within the range linked to your specific gene mutation: BRCA1 carriers aged 25–40, BRCA2 carriers aged 25–45…

People who have been diagnosed with a confirmed advanced-stage (Stage III or IV) high-grade cancer of the ovaries, fallopian tubes, or peritoneum of a specific type (serous or endometrioid). People who have received 1 or 2 previous treatment courses for advanced or spread cancer, where at least one treatment included…

Adults aged 18 or older, or teenagers aged 12–17 if a Safety Review Committee has given approval for that age group. People who have a solid tumour (cancer that forms a mass) that has spread locally or to other parts of the body, and whose tumour has a specific genetic change called a TP53 Y220C mutation. People whose…

You are 18 years of age or older You are fairly active and able to care for yourself, with little or no limitation on daily activities (this is measured by a standard scale called ECOG, scored 0 or 1) You are willing and able to sign a consent form and follow all study requirements Your cancer has been confirmed by a…

Adults aged 18 or older People with solid tumour cancers that have come back or spread, who have already received appropriate standard treatment for their cancer type and stage, or where a clinical trial is considered the best next treatment option by the doctor in charge People whose cancer can be measured on scans…

People aged 18 or older People diagnosed with high-grade serous ovarian cancer, fallopian tube cancer, or primary peritoneal cancer People whose tumor testing (which can be done on stored tissue samples) shows a positive result for a protein called Cyclin E1, measured using a specific test provided by the trial…

People with advanced or metastatic hormone receptor-positive, HER2-negative breast cancer that has continued to grow after treatment with a specific type of cancer drug called a CDK4/6 inhibitor (given either after surgery or for advanced disease) People with advanced or metastatic high-grade ovarian, fallopian tube…

People who are able to give signed consent and agree to follow the study's requirements. People who are willing to provide an optional genetic research consent form before any genetic samples are collected (declining this does not prevent someone from joining the study). People who are 18 years of age or older at the…

Adults aged 18 or older who have a good general level of physical functioning (rated 0 or 1 on a standard oncology scale, meaning fully active or able to carry out light activities) People with certain advanced or spread cancers, depending on which part of the trial they would be enrolled in — including hormone…

Women who are at least 18 years old People who are willing and able to follow the study requirements and have signed a consent form People who have been diagnosed (confirmed by laboratory testing of tissue) with recurrent or persistent clear cell carcinoma of the ovary, endometrium, cervix, vagina, or vulva — with…

People who have been confirmed by biopsy to have low-grade serous ovarian, fallopian tube, or peritoneal cancer (LGSOC) People whose tumour has been tested for a gene change called KRAS, using an approved tumour tissue test People whose cancer has come back or gotten worse after at least one previous systemic…

People aged 18 or older who are willing and able to sign a consent form before any study procedures begin People with skin (cutaneous) melanoma — including acral (affecting palms or soles) or non-acral types — that has been confirmed by laboratory testing, and whose disease has continued to grow or spread after at…

People who are female and aged 18 or older. People who have advanced solid tumours and have already received appropriate standard treatments for their tumour type, or where the treating doctor considers a clinical trial to be the best next option. People whose cancer has spread or come back in the local region, and…

Adults aged 18 or older who have been diagnosed with an advanced solid tumour (confirmed by laboratory analysis of tumour tissue or cells) that has already been treated with standard treatments, or for which no standard treatment is available. People who are willing to provide a stored tumour tissue sample if one…

Adults aged 18 or older who are able to give informed consent People whose general health and blood test results meet the required standards set by the trial People who have a stored tumour tissue sample available, or who are able to have a fresh tumour biopsy taken; people for whom a fresh biopsy is not safely…

People who have been diagnosed with a solid tumour cancer, confirmed through a tissue or cell sample. People who are 18 years of age or older. People who have at least one tumour measuring 1 cm or more visible on a recent PET/CT scan (a type of imaging scan). A small number of participants may be enrolled even if…

People who have a confirmed diagnosis of epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that shows high levels of a protein called folate receptor alpha (FRα) on the tumour cells. People whose tumour has been tested and confirmed as "FRα high" using a specific approved laboratory test…

You have been diagnosed with one of the following cancers (depending on which part of the trial you join): ovarian cancer (including primary peritoneal or fallopian tube cancer), endometrial cancer, cervical cancer, non-small cell lung cancer, triple negative breast cancer, pancreatic cancer, or colorectal cancer For…

People who have one of the following solid tumour cancers, depending on the group (cohort) they would be placed in: urothelial carcinoma, triple negative breast cancer, non-small cell lung cancer, esophageal cancer, pancreatic cancer, ovarian cancer, cervical cancer, head and neck squamous cell carcinoma, or prostate…

People who are at least 18 years old at the time of signing the consent form People whose general health and ability to carry out daily activities meets a certain standard (rated 0 or 1 on a scale used by doctors to measure this) People who have a confirmed solid tumour — including but not limited to breast, ovarian…

People who previously took part in the MNPR-101-D001 study. Women who could become pregnant must have a negative pregnancy blood test at the screening visit, and a negative pregnancy urine test on the first day of treatment if screening took place more than 7 days earlier. Both men and women must agree to use highly…

People who have been diagnosed with high-grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer (confirmed by testing). People whose cancer has stopped responding to platinum-based chemotherapy in one of these ways: those who had 1 previous course of platinum-based treatment (at least 4…

People who are female and aged 18 or older at the time of signing the consent form People who are willing and able to sign the consent form and follow the study requirements People who have been diagnosed (confirmed by lab testing of tissue) with advanced (cannot be removed by surgery) or metastatic high-grade serous…

You are 18 years of age or older at the time of signing the consent form. You are able to understand and willing to sign a written consent form agreeing to take part. You are reasonably active and able to care for yourself, with limited or no restriction on daily activities (based on a standard cancer performance…

You must be willing to sign consent forms before any trial-related procedures begin, including consent for optional genetic testing. You must be 18 years of age or older at the time of signing the consent form. You have been diagnosed with a specific type of ovarian, fallopian tube, or primary peritoneal cancer (a…

People who have been diagnosed with Stage III or IV ovarian cancer, primary peritoneal cancer, or fallopian tube cancer of certain tissue types, confirmed by laboratory testing People who have received 4 or more cycles of a platinum-based chemotherapy combination as their first treatment, and a total of 6 cycles of a…

Adults aged 18 or older. People with advanced solid tumour cancers that have been confirmed by laboratory testing of tissue or cell samples, where the cancer has continued to grow despite standard treatment, or where no standard treatment exists. People who are largely able to carry out daily activities with little or…

People who have been confirmed by tissue testing to have a specific type of cancer called high-grade serous cancer, affecting the ovaries, fallopian tubes, or the lining of the abdomen (peritoneum). People whose cancer has stopped responding well to platinum-based chemotherapy — specifically, those who had only one…

You must be willing to provide a stored tumor tissue sample or agree to a new tumor biopsy (using a low-risk, routine procedure) so that the tumor can be tested for a specific protein called FRα — and at least half of your tumor cells must show a strong enough level of this protein. You must be generally well enough…

People who have been diagnosed with high-grade serous ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed by a tissue sample analysis. People whose cancer has stopped responding to platinum-based chemotherapy (known as platinum-resistant disease), with specific timing requirements depending…

You have been diagnosed with a specific type of ovarian cancer called high-grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer. Your cancer has stopped responding to platinum-based chemotherapy (a common type of cancer treatment) in one of these ways: if you had only one course of platinum…

You have been diagnosed with high-grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer, confirmed through a laboratory analysis of tissue samples.

People who are at least 18 years old and meet the legal age of consent in the country where the trial is taking place. People who have been diagnosed with a specific type of ovarian cancer (including primary peritoneal or fallopian tube cancer), confirmed by laboratory testing, with one of the following cancer types…

People who have been diagnosed with a specific type of ovarian, peritoneal, or fallopian tube cancer that has been confirmed through laboratory testing of tissue samples People who have completed surgery to remove as much of the tumour as possible (either before or during chemotherapy) People who have finished a first…

People who are able to give written consent and understand what the study involves, including its purpose and potential risks Adults aged 18 or older at the time of screening People with a life expectancy of at least 3 months People whose cancer has been confirmed by laboratory testing (tissue or cell sample) and…

You are between 50 and 74 years old (inclusive). You have gone through menopause naturally or had a hysterectomy, and have had no periods for at least 12 months in a row — OR you have been on hormone replacement therapy (HRT) for menopausal symptoms for at least 12 months. You are willing and able to give written…

You are a woman aged 18 or older You have been diagnosed with a specific type of ovarian, peritoneal, or fallopian tube cancer (high-grade serous type) Your cancer can be measured on scans, following a standard set of measurement guidelines You are generally active and able to care for yourself, with only minor…

You have been diagnosed with a specific type of ovarian cancer (non-mucinous epithelial ovarian cancer), or a related cancer starting in the peritoneum or fallopian tubes, confirmed by a lab test Your cancer can be measured on a CT or MRI scan Your cancer has come back between 6 and 24 months after finishing your…

People who have been diagnosed with a recurrent form of epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer through a tissue biopsy. People whose cancer is one of these specific types: serous adenocarcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, undifferentiated carcinoma…

You have been diagnosed with stage I, II, or III lung cancer (non-small cell type), breast cancer, or ovarian cancer — stage IV does not qualify. You are planning to start chemotherapy using a taxane-based drug (such as docetaxel or paclitaxel) within 14 days of signing up for the trial, as part of one of the specific…

You have been diagnosed with stage III or IV ovarian cancer, primary peritoneal cancer, or fallopian tube cancer, confirmed by a tissue or cell sample Your cancer is a specific type called adenocarcinoma, and you have a large pelvic or abdominal tumour and/or fluid build-up around the lungs Your doctors believe it is…

You have been diagnosed with ovarian cancer or primary peritoneal cancer (a related cancer starting in the lining of the abdomen), confirmed by a laboratory test on a tissue sample Your cancer has come back or has not gone away completely You have at least one tumor that can be measured on a scan (at least 20mm using…

You are willing to sign a consent form agreeing to take part in the study You are willing to have a tumor biopsy taken, and your tumor is in a location that can be safely biopsied (first group of participants only) You are 18 years of age or older You have been diagnosed with advanced ovarian cancer confirmed by…

You have been diagnosed with a specific type of ovarian cancer (non-mucinous ovarian adenocarcinoma), confirmed by a lab test on tissue. Your ovarian cancer (Stage 3) has come back or has not fully gone away after treatment with platinum- and taxane-based chemotherapy, and the cancer is inside the abdomen. The…

You have been diagnosed with epithelial ovarian cancer, confirmed by a lab test of tissue samples Your cancer has stopped responding to platinum-based chemotherapy, meaning it either got worse during that treatment or came back within 6 months of finishing it Your cancer can be measured or detected — this includes…

You have been diagnosed with ovarian cancer or peritoneal cavity cancer that was confirmed by a tissue sample (biopsy) Your cancer came back or stopped responding after your first treatment, which must have included a platinum-based chemotherapy drug Your cancer may have either responded to platinum treatment…

People who have been diagnosed with epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer through a tissue biopsy, at an advanced stage (stage III with remaining visible tumour, or stage IV), confirmed after initial abdominal surgery People whose cancer is one of several specific cell types…

You have been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (confirmed by lab testing) that has come back or stopped responding to initial treatment. You have previously been treated with a platinum-based chemotherapy drug before joining this trial. Your cancer can be…

You have been diagnosed with a soft tissue sarcoma (a type of cancer) of the female reproductive system, specifically uterine leiomyosarcoma, malignant mixed mullerian tumor/carcinosarcoma, or a similar cancer starting in the ovary or fallopian tube (confirmed by lab testing) Your cancer cannot be fully removed by…

People aged 18 or older. People who have ovarian cancer or primary peritoneal cancer that has come back, continued to grow, or not gone away after being treated with platinum-based and taxol-based chemotherapy drugs, with the original tumour confirmed by laboratory tissue testing, and who have had both ovaries…

You have ovarian cancer or primary peritoneal cancer that has come back or has not gone away after treatment. Your cancer can be measured on scans or tests, and there is at least one specific area of cancer that doctors can track to see if the treatment is working. You are not eligible for a higher-priority study…

You are a woman who has been diagnosed (confirmed by lab testing) with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer of the serous type that has come back, and your cancer responded to your 2nd, 3rd, or 4th round of chemotherapy. Your cancer responded to treatment, meaning your CA125…

You have been diagnosed with advanced ovarian cancer (stage III or IV) or a related cancer called primary peritoneal cancer, confirmed by laboratory testing of tissue samples. After surgery to remove the tumor and 4 to 6 rounds of standard chemotherapy (using platinum and taxane-based drugs), all signs of cancer have…

You are scheduled to receive your own previously collected stem cells back (called an autologous stem cell transplant). You speak and understand English. Your stem cell infusion is planned to take place at the SCCA outpatient clinic.

You are 18 years old or older You have been diagnosed with ovarian cancer or primary peritoneal cancer, confirmed by a tissue sample (biopsy), including types such as mucinous, serous, endometrioid, clear cell, or undifferentiated tumors Your cancer can be measured on scans or imaging (at least one visible area of…

People who have been diagnosed with certain cancers confirmed by laboratory testing, including non-small cell lung cancer, melanoma, bladder or urinary tract cancer, kidney cancer, triple negative breast cancer, uterine cancer, head and neck cancer (Phase 1), or ovarian cancer, bowel cancer with a specific genetic…

You have been diagnosed with one of the following advanced or spreading cancers, confirmed by a lab test: small cell carcinoma (at least 3rd line treatment or platinum-resistant/refractory in 2nd line), a specific type of non-small cell lung cancer with an EGFR mutation (after prior platinum and targeted therapy)…

The person must provide written agreement to take part before any trial-related procedures begin. The person must be older than 10 years of age. The person must have a good general health and activity level, rated 0 or 1 on a standard medical scale (meaning fully active or able to carry out light work). The person…

The person has a confirmed diagnosis of a specific type of ovarian, primary peritoneal, or fallopian tube cancer — including high-grade serous, endometrioid, carcinosarcoma, mixed mullerian with a high-grade serous component, clear cell, or low-grade serous types (only up to 8 people with clear cell carcinoma will be…

You must be 21 years of age or older You must be able to speak English You must be a registered attendee of the advanced 7-day meditation retreat You must be willing to wear a Garmin wearable device for the entire duration of the retreat You must agree to and sign the research consent form to take part in the study…

People who are 18 years of age or older at the time of their clinic visit being reviewed for this study. People who have existing genetic test results or medical records showing a diagnosis of Hereditary Breast and Ovarian Cancer (HBOC) syndrome or Lynch Syndrome (LS) — two inherited conditions that raise the risk of…

People who have been diagnosed with confirmed ovarian cancer People whose doctors have determined that a certain type of upfront surgery (called primary debulking surgery) is not possible, based on a specific medical assessment score, and who have been referred for chemotherapy given before surgery People who have…

Doctors, physician assistants, or nurse practitioners who saw patients at trial sites during the study period may be eligible to participate. Clinicians who had patient visits — whether in an emergency room, as a hospital inpatient, or in an outpatient setting — where the patient had medical imaging that showed a…

People who are 18 years of age or older, of any gender. People who have a known harmful change in a gene linked to cancer risk, which was found by a certified laboratory more than one year ago. People who are able to accurately answer questions about themselves, based on a clinician's assessment that their thinking…

The person has signed a written consent form agreeing to take part. The person is 18 years of age or older. The person has been diagnosed with advanced ovarian cancer (Stage III or IV) and is scheduled for surgery. The person has received neoadjuvant chemotherapy (a minimum of 3 cycles and a maximum of 6 cycles)…

You are between 18 and 75 years old and have been assessed by an anesthesiologist as being in generally good to average health (rated ASA grade I or II) You are scheduled for a planned surgery for ovarian cancer that involves removing the uterus and possibly other nearby tissues, lymph nodes, or the appendix

People who are able and willing to sign a consent form before any study-related procedures begin. Women aged 18 or older who have been diagnosed with stage III or IV ovarian cancer (adenocarcinoma type) that has stopped responding to platinum-based treatment within 6 months, and whose cancer can be measured using…

People who have been newly diagnosed with stage III epithelial ovarian cancer (including cancer of the peritoneum or fallopian tubes), based on the FIGO classification system. People who have had upfront surgery where most of the tumour was removed, leaving behind less than 1 cm of remaining tumour. People who are…

Adults aged 18 years or older. People with advanced ovarian, fallopian tube, or primary peritoneal cancer who are considered suitable for chemotherapy given before surgery, or people whose cancer has come back at least 6 months after finishing their last platinum-based chemotherapy treatment. People who are reasonably…

People aged 18 to 80 years old (inclusive) who are female. People who have been diagnosed with ovarian cancer confirmed by a tissue sample (biopsy), can provide the pathology report, and whose cancer is classified as stage III or stage IV. People whose ovarian cancer has stopped responding to platinum-based…

Adults aged 18 or older who are female. People who have a suspected or possible growth in the area near the ovaries that requires surgery to remove tissue for testing. People who have had a pelvic imaging scan before surgery, such as an ultrasound, MRI, CT scan, or PET/CT scan. People who have had specific blood tests…

People who are 18 years of age or older. People who have been diagnosed with a specific type of ovarian cancer called high-grade serous ovarian cancer (HGSOC) through a tissue or cell sample, or who are strongly suspected to have this cancer based on symptoms, physical examination, tumour markers, and scan results.…

The person is willing and able to sign a consent form and follow the trial's treatment and check-up schedule. The person is 18 years of age or older (based on the date the consent form is signed). The person has been diagnosed through laboratory testing with a specific type of ovarian, primary peritoneal, or fallopian…

People who are 18 years of age or older. People who are able to understand what the trial involves and agree to take part by giving informed consent. People who have been diagnosed with ovarian cancer that has come back after previous treatment.

The person has voluntarily agreed to take part and has signed a consent form. The person is between 18 and 75 years old. The person has a laboratory-confirmed diagnosis of high-grade mainly serous ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; or a moderately or poorly differentiated type of…

People who are willing to take part voluntarily, sign a consent form, follow the study rules, and attend follow-up appointments. Women aged 18 or older at the time of signing the consent form. People who have been confirmed by pathology (laboratory testing of tissue) to have high-grade serous ovarian cancer, fallopian…

Women aged 18 or older. People diagnosed with high-grade serous or endometrioid ovarian cancer, primary peritoneal cancer, or fallopian tube cancer. People who are willing and able to sign a written consent form. People with a good general level of functioning, able to carry out normal daily activities with little or…

Women aged 18 to 75 years old. People who have been diagnosed through tissue or cell testing with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. People who previously received platinum-based chemotherapy as their first treatment, and either: their cancer came back or got worse within 6…

Women aged 18 years or older at the time of signing consent forms. People who are willing and able to attend all scheduled visits, follow study procedures, and complete required tests and treatments. People who have been diagnosed through tissue testing with primary epithelial invasive ovarian cancer of any grade…

People who have been diagnosed with stage IB to IVA cervical cancer, confirmed by a tissue sample test, using the 2018 FIGO staging system. People whose treating doctor determines they are able to have surgery, or full-course radiation therapy and chemotherapy. People aged between 18 and 80 years old. People who have…

People aged 18 to 75 who have been newly diagnosed with advanced ovarian cancer (stage III or IV), who had surgery to remove as much of the tumour as possible, followed by 6 to 8 rounds of chemotherapy using standard drug combinations. People whose general physical health is rated as fully active or able to carry out…

People who have recently been diagnosed with a malignant (cancerous) ovarian germ cell tumour. People who have recently been diagnosed with a non-cancerous ovarian germ cell tumour, or who have no known gynaecological condition (these people would be part of a comparison group in the study).

People who are able to understand and sign a written consent form. People aged 18 years or older, of any gender. People who have been confirmed by tissue testing to have advanced or metastatic solid tumours that have not responded to at least two previous treatment lines, or who have been newly diagnosed with advanced…

People who have given their full informed consent and signed a written consent form agreeing to take part in the study. People aged between 18 and 75 years old. People who have been confirmed by pathology (laboratory testing of tissue) to have epithelial ovarian cancer, epithelial fallopian tube cancer, or primary…

A gynaecological ultrasound examination found at least one persistent ovarian tumour (a growth on the ovary that did not go away). The person had surgery, and tissue samples from the surgery were examined under a microscope to identify what the growth was.

People with a good general health and activity level, rated 0 or 1 on a standard performance scale (where 0 means fully active and 1 means slightly restricted). People newly starting treatment who have been diagnosed (confirmed by laboratory tissue testing) with high-grade serous ovarian cancer, fallopian tube cancer…

People who have high-grade serous ovarian cancer (an aggressive type of ovarian cancer) that does not have changes in the BRCA gene, and whose cancer has been tested and found to be "HRP" (meaning the cancer cells have a normal ability to repair their DNA). People who had no cancer remaining after their first surgery…

People who are willing to sign a consent form agreeing to take part in the study. Women aged 18 to 74 years old. Women who have been diagnosed through a tissue sample (biopsy or similar procedure) with a specific type of ovarian, peritoneal, or fallopian tube cancer (high-grade serous, endometrial, or clear cell…

People who have previously been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. People who were receiving PARP inhibitor treatment (a type of cancer medication) before their cancer came back. People whose scans show they are suitable for further surgery to remove the cancer, and who…

People with suspected or confirmed ovarian cancer who are scheduled to have surgery to remove the tumour. People who have been confirmed through laboratory tissue testing to have a specific type of ovarian cancer called high grade serous ovarian cancer. People who have given written consent to participate in the trial.

Women aged 18 years or older People who have been diagnosed through laboratory testing with stage I to stage IV epithelial ovarian cancer (a specific type of ovarian cancer) People whose physical functioning is rated at a certain level based on a standard medical scale, meaning they are able to carry out at least some…

People who are willing to take part and have signed a consent form agreeing to join the study. People aged 18 to 75 years old at the time of signing consent. People with an expected survival of at least 12 months. People with a good general level of physical functioning (an ECOG performance score of 0 or 1, meaning…

People aged 18 to 70 years old who are female. People who have been diagnosed through laboratory testing (including biopsy) with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, where the cancer came back within less than six months after completing a chemotherapy treatment that…

People aged 18 to 79 years old at the time their cancer came back. People with epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer that has come back for the first time and responded to platinum-based chemotherapy, meaning treatment ended at least 6 months before the cancer returned. If the…

You are a patient at the South Egypt Cancer Institute who has recently been diagnosed with ovarian cancer You have not yet had surgery for your ovarian cancer

People with recurrent, advanced, or metastatic ovarian or endometrial cancer that got worse during or after standard treatment. People aged 18 years or older. People with a general health and activity level rated 0 or 1 on a standard medical scale (meaning fully active or able to carry out light work — confirm with…

People who are able to give written consent and are willing to follow the study procedures as outlined in the consent form. People who have been diagnosed with high-grade serous ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed by tissue testing. People who have not yet received…

People diagnosed with epithelial ovarian cancer that appears to be at an early stage (stage I or II) based on pre-surgery scans (CT and/or MRI), with no enlarged lymph nodes in the back of the abdomen, or with only slightly enlarged lymph nodes (less than 1 cm across their shortest measurement). People aged between 18…

People who are willing to take part voluntarily and have signed and dated a consent form. People who are 18 years of age or older at the time they sign the consent form. People who have been diagnosed with an advanced solid tumour cancer (confirmed by tissue or cell testing) that has stopped responding to standard…

Women between 35 and 50 years of age. Women who are attending or being followed up in a genetic counselling service related to cancer risk. Women who have been identified as having a higher risk of ovarian, fallopian tube, or peritoneal cancer based on specific gene mutations (BRCA1, BRCA2, RAD51C, RAD51D, or PALB2 —…

Women of reproductive age, between 18 and 45 years old. People who have been diagnosed with ovarian cancer that is localized (meaning it has not spread widely). People who are having surgery as part of their treatment.

Adults between the ages of 19 and 75. People who have been diagnosed with ovarian cancer at stage 2 or 3 (as defined by a standard cancer staging system called FIGO). People who finished their first round of chemotherapy for ovarian cancer (not including any ongoing maintenance therapy) within the last 2 years.

People aged 18 or older (any gender). People whose doctors expect them to survive at least 3 months. People with a good general level of physical functioning, able to carry out normal daily activities with little or no restriction (confirm with trial site — this refers to an ECOG score of 0–1). People who have a…

People newly diagnosed with advanced-stage (stage IIIC or IV) ovarian cancer, fallopian tube cancer, or primary peritoneal cancer between December 2013 and December 2024. Complete records of their initial cancer treatment and any maintenance therapy must be available. Follow-up health information after treatment must…

People aged 18 or older. People whose general health and ability to carry out daily activities meets a certain minimum level (measured by standard performance scales used by doctors). People with epithelial ovarian, fallopian tube, or peritoneal cancer that has come back or stopped responding to treatment, confirmed…

The person is willing to give written, signed, and dated consent to take part in the study. The person is female and aged 18 or older. The person has been diagnosed, confirmed by laboratory testing of tissue or cell samples, with a specific type of ovarian, fallopian tube, or primary peritoneal cancer called…

Women aged 18 years or older. People who have been diagnosed with a gynaecologic cancer (such as ovarian, endometrial, cervical, or vulvar cancer) that requires surgery. People whose planned surgery includes removal of part of the bowel and reconnection of the remaining bowel ends. People who are able and willing to…

People newly diagnosed with stage I–IV colorectal or ovarian cancer, grade 1 or 2 endometrial cancer, brain tumors, or sarcoma. People who have surgery planned for at least 2 weeks after the day they enroll in the study. People who are able to understand and willing to sign a written consent form for this study and a…

Women aged 18 or older who are able to understand the study procedures and agree to take part by signing a written consent form. People who have been diagnosed with epithelial ovarian cancer confirmed through laboratory tissue testing. People whose cancer meets the approved treatment criteria as a maintenance therapy…

You are a woman aged 18 or older You have been diagnosed with ovarian cancer (a specific type called epithelial ovarian cancer, confirmed by lab testing) at any stage, and have received no more than 2 previous rounds of treatment (not counting maintenance therapy) Your cancer came back more than 6 months after your…

People who are receiving paclitaxel and carboplatin chemotherapy for a gynaecological cancer. People who have never had an allergic reaction to paclitaxel or carboplatin in the past. People who are able to read and are willing to sign a written consent form agreeing to take part. People who are 19 years of age or…

You are older than 18 years of age You have recently been diagnosed with stage III or stage IV ovarian cancer You are able to receive a type of chemotherapy that contains platinum (confirm with trial site) After 3 to 4 cycles of chemotherapy given before surgery, your cancer has either partially responded to treatment…

The person is willing to take part and has signed a consent form agreeing to join the trial. The person is a woman aged 18 to 75 years old (inclusive). The person has been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed by tissue or cell testing. The person has…

People who are willing to join the study, sign a consent form, follow the study requirements, and attend follow-up visits. Women aged 18 to 75 years old (inclusive) at the time of signing the consent form. People who have been diagnosed through tissue or cell testing with epithelial ovarian cancer, fallopian tube…

There must be at least six trainee doctors specializing in women's health (gynecology residents) who attend the ultrasound center every day, with overlapping work shifts. Patients who have been diagnosed with, or are suspected of having, a cancer affecting the female reproductive system — including ovarian, womb…

People who are willing to give their consent to participate and are able to follow the trial schedule, including visits, treatments, and tests. Women aged 18 or older at the time of signing the consent form. People who have been diagnosed by a pathologist with epithelial ovarian cancer, fallopian tube cancer, or…

Adults aged 18 years or older. People diagnosed with advanced ovarian cancer at a specific stage (FIGO stage IIIB to IVB, which refers to cancer that has spread to the lining of the abdomen or beyond). People who are well enough to undergo upfront surgery to remove as much of the cancer as possible (called…

You are willing to give your consent to participate and are able to follow the treatment plan and attend follow-up appointments. You are 18 years old or older. You are able to carry out normal daily activities with little or no limitations (confirm with trial site — this refers to a performance score of 0 or 1). You…

You have been diagnosed with a specific type of advanced ovarian cancer (high-grade serous ovarian adenocarcinoma, at stage IIIC or IVA), confirmed by a tissue sample test. You are between 18 and 70 years old. Your doctors expect you to live for at least 12 more months. You have received a specific score from two…

The person agrees to take part willingly and signs a consent form. The person is a woman aged between 18 and 70 years. A tissue sample has confirmed an advanced (Stage III or IV) diagnosis of serous or endometrioid ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma. The cancer came back within 6…

People who have signed the written consent form for the study. People aged 18 or older, of any gender. People with a life expectancy of at least 12 weeks. People with a good general level of physical functioning, as measured by a standard oncology scale (ECOG score of 0 or 1), meaning they are fully active or have…

People who have been diagnosed with a type of cancer that can sometimes be linked to hereditary (inherited) forms of cancer.

Women aged 18 to 75 years old. There are measurable areas of cancer visible on scans at the start of the trial, assessed using a standard measurement system called RECIST 1.1. The person is reasonably active and able to care for themselves, based on a standard performance scale scored 0 or 1 (confirm with trial site).…

People who are willing to take part voluntarily, have signed a consent form, are able to follow the study requirements, and are willing to attend follow-up appointments. People aged between 18 and 75 years old (calculated from the date the consent form is signed). People who have been newly diagnosed with epithelial…

People who are able to give written consent and follow the visit schedule and procedures required by the trial. People aged 18 to 75 years, of any gender. People with a physical functioning score of 0 or 1 on a standard cancer performance scale (meaning they are fully active or have only minor restrictions on…

Women aged 18 or older People with a laboratory-confirmed diagnosis of primary epithelial ovarian cancer at stage I through IV People with an ECOG performance score of less than 2, meaning they are able to carry out daily activities with little to no restriction (confirm with trial site) People whose doctors expect…

People who have hereditary breast and ovarian cancer (HBOC), Lynch syndrome, or a condition involving intestinal polyps, and whose samples are being tested using specific genetic testing tools provided by Sophia Genetics and run on Illumina equipment. People with rare or inherited disorders whose samples have already…

People who have been diagnosed with ovarian clear cell carcinoma, confirmed by laboratory testing of tissue samples. People whose cancer has continued to grow (shown on imaging) after receiving immunotherapy treatments (such as anti-PD-1, PD-L1, or PD-1/PD-L1+CTLA4), and who have since received a treatment called…

Women aged 18 years or older People who have already been recommended by a breast specialist team to have a nipple-sparing mastectomy (breast removal while keeping the nipple) with immediate implant reconstruction for one of the following reasons: carrying a gene mutation that increases breast cancer risk…

People who are willing to take part and have signed a written consent form agreeing to participate. People aged between 18 and 75 years who have been diagnosed through a tissue biopsy with ovarian clear cell carcinoma that has come back or has not gone away after treatment. People who have already received at least…

People who are 18 years of age or older. People who have been diagnosed through laboratory testing with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer — note that mucinous carcinoma and low-grade serous carcinoma types are not eligible. People who have at least one tumour or lesion that…

People included in the retrospective (past records) part of the study must have had a diagnosis of advanced or returning gynaecological cancer that involved major blood vessels and required surgery to remove or reconstruct those vessels — this includes ovarian, cervical, endometrial, or vulvar cancer, or uterine and…

You must be 18 years old or older You have been diagnosed with an early-stage ovarian or fallopian tube tumor (specifically FIGO 2018 stage IA or IB, which means the cancer is at an early stage and has not spread beyond the ovaries or fallopian tubes) You have had a full set of pre-surgery tests completed, including…

Women between the ages of 19 and 85 years old. People who have been diagnosed with ovarian, fallopian tube, or peritoneal cancer, confirmed through laboratory testing of tissue samples. People whose cancer either progressed during platinum-based chemotherapy (refractory), or came back within 6 months of finishing…

People who have been newly diagnosed with stage III or IV ovarian cancer, or whose ovarian cancer has come back within six months of their original diagnosis or return of the cancer People who are 18 years of age or older People who are able to speak and read English People who are able to give their informed…

People who have had their first recurrence of a specific type of ovarian, fallopian tube, or primary peritoneal cancer (invasive epithelial type), regardless of what stage it was when first diagnosed. People whose cancer did not come back until at least 6 months after finishing their last platinum-based chemotherapy…

People who are able to sign a written consent form before any trial-related procedures begin. People who are female and aged 18 or older. People who have been diagnosed with epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer (confirmed by tissue testing), and whose cancer has come back…

Specialist gynaecological cancer surgeons who are involved in operating on patients with ovarian cancer Gynaecological cancer surgeons who have a high level of expertise in ovarian cancer surgery and have been practising independently for a number of years Gynaecological cancer surgeons who hold a leading or…

People who have chosen to take part voluntarily and have signed a consent form. People aged 18 or older (from the date the consent form is signed). People who have been newly diagnosed (confirmed by a tissue sample) with high-grade serous ovarian cancer, fallopian tube cancer, or primary peritoneal cancer; or ovarian…

People who have been diagnosed with returning ovarian cancer, fallopian tube cancer, or primary peritoneal cancer of a specific type, confirmed through laboratory testing of tissue or cell samples (specific cancer types include high-grade serous carcinoma or grade 2/3 endometrioid carcinoma). People whose BRCA 1/2…

People aged between 18 and 85 years old. People who have been diagnosed through a tissue biopsy with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, specifically the high-grade serous or endometrioid types. People who are fully active or able to carry out light work (as measured by a…

Women between 18 and 75 years old at the time of giving consent to participate. People who have been newly diagnosed with a confirmed type of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, specifically high-grade serous or high-grade endometrioid types. People whose cancer was classified as an…

(Related to the cervical cancer part of the study) Adult women who have had a normal cervical smear in the past three years and have no other gynaecological cancers (this group acts as a comparison group). (Related to the cervical cancer part of the study) Adult women who have been diagnosed with cervical cancer or…

Adults aged 18 or older who have been diagnosed with an advanced (spread or inoperable) solid tumour, confirmed by laboratory testing of a tissue sample. People whose tumour tissue (either a stored sample or a new biopsy) shows a specific protein called NY-ESO-1, confirmed by a central laboratory test. People with…

Women between 18 and 75 years of age. People who have been diagnosed through a tissue sample (from surgery or biopsy) with a specific type of ovarian, abdominal lining, or fallopian tube cancer that is at an advanced stage (Stage III or IV). People who have at least one area of cancer that can be measured on a CT or…

People who are willing to take part voluntarily, sign a consent form, and follow the study rules closely. Women aged between 18 and 75 years. People who have had open surgery, keyhole surgery, or a needle biopsy, and whose tissue results confirmed a diagnosis of epithelial ovarian cancer (specific types: high-grade…

People who are 18 years old or older at the time of agreeing to take part in the study People who are able to give their free and willing written agreement to participate People who are attending specialist gynaecology (women's health) outpatient services People who are able to tolerate a vaginal speculum examination…

People who are 18 years of age or older. People who have been diagnosed through a tissue biopsy with high-grade serous ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. People whose cancer has been classified as an advanced stage (stage 3C or stage 4) using an international staging system for…

Women aged 18 to 75 years who are willing and able to give written consent and follow the study requirements. People with a laboratory-confirmed diagnosis of recurring non-mucinous epithelial ovarian cancer, including serous carcinoma, clear cell carcinoma, endometrioid carcinoma, or carcinosarcoma. People…

Women between 18 and 70 years old (including those ages) who weigh at least 45 kg. People whose cancer did not fully respond to at least one round of standard treatment (surgery and platinum-based chemotherapy), and who still have abnormal CA125 blood levels or at least one area of cancer that can be measured on a…

People aged 25 years or older. People who have given their informed consent to participate in the trial. People who have been diagnosed with high-grade serous ovarian carcinoma, confirmed through tissue analysis and/or surgery. People who have not yet had surgical treatment for their condition. People who have tumor…

Women aged 18 to 75 years old. People who are willing to sign a consent form agreeing to take part voluntarily. People who have been diagnosed with ovarian cancer confirmed by laboratory testing of tissue, with no need for an additional biopsy during the screening period. People with platinum-resistant recurrent…

People who have been diagnosed with ovarian cancer that is either at an early stage (limited to a small area) or a more advanced stage. People who are able and willing to fill out study questionnaires. People who can understand and speak the language in which the questionnaires are written. People who are over 18…

Adults aged 18 years or older, of any gender People who have been diagnosed with lung cancer, or where doctors strongly suspect lung cancer based on CT, PET, or other scans taken within 4 months of the screening visit, or people who have been diagnosed with ovarian cancer People who are already scheduled to have…

People who are 18 years of age or older at the time of signing the consent form. People who are in reasonably good general health and able to tolerate chemotherapy, as assessed by a standard medical scoring system (called ECOG performance status 0–1). People who have disease that can be measured on scans, according to…

Gynecologists (specialist doctors focused on women's health) who work in outpatient clinic settings and who currently offer ovarian cancer screening to women who have no symptoms and are not considered high risk, which is not in line with standard medical guidelines.

People who have been diagnosed with high-grade serous or endometrioid epithelial ovarian cancer (including fallopian tube, ovarian, or primary peritoneal cancer), confirmed by tissue testing. People whose cancer is considered "platinum-sensitive," meaning the cancer did not come back or get worse until at least 6…

People who have been diagnosed with advanced ovarian cancer (stages 3 or 4). People whose doctors have recommended chemotherapy before surgery, followed by surgery to remove as much of the cancer as possible. People who have no medical reasons preventing them from taking part in an exercise program. People who are…

Children from birth up to (but not including) 18 years old, of any gender. Children who have a medical need for keyhole (laparoscopic) surgery on the chest or abdomen, and who are healthy enough to undergo that type of surgery. A parent or legal guardian has given written permission for the child to take part; if the…

You are between 19 and 75 years old and have been diagnosed with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has a BRCA gene mutation and is classified as high-grade Your body mass index (BMI) — a measure of body weight relative to height — is between 18.0 and 28.0

People who were seen at the Breast and Ovarian Cancer Risk Evaluation Clinic or the Cancer Genetics Clinic at the University of Michigan Rogel Cancer Center within the past year, and who tested positive for a hereditary breast and ovarian cancer gene change (BRCA1 or BRCA2), or Lynch Syndrome gene change (MLH1, MSH2…

People who are willing to voluntarily sign the consent form and follow the study requirements. People who are aged 18 to 75 years old on the day they sign the consent form. People who are expected to live for at least 3 months. People whose cancer has been confirmed by laboratory testing (from tissue or cell samples)…

Adults between 18 and 80 years of age (inclusive). People with a performance status score of 0–2, which is a doctor's rating of how much a person's daily activities are affected by their illness (confirm with trial site). People who have been diagnosed with primary epithelial ovarian cancer (confirmed through…

People who are willing to give their written agreement to take part in the study voluntarily. People who have been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed through laboratory testing of tissue or fluid samples. People who are 18 years of age or older.…

Women between 18 and 75 years of age at the time of signing consent. People who have been diagnosed through laboratory testing with a specific type of cancer affecting the ovaries, fallopian tubes, or the lining of the abdomen (peritoneum), at an advanced stage (FIGO stage II–IV). People whose cancer came back and…

Women aged between 18 and 90 years old People having open abdominal surgery to remove a growth on one or both ovaries or fallopian tubes People whose tissue sample, examined during surgery, shows a malignant or borderline ovarian tumour of a specific type (epithelial) People with growths on both ovaries or fallopian…

The person must be female. People who have an ovarian or adnexal (near the ovary) mass and are scheduled to have surgery or a biopsy/tissue sample taken for the first time at the participating centre for this current growth, with a confirmed tissue diagnosis expected to be available. Scans done during the screening…

People who are female People who are 18 years of age or older People who are scheduled to have surgery to remove an ovarian mass that is suspected or confirmed to be cancerous People whose surgery is planned at least 3 weeks after the time of booking People who do not have any reasons that would make exercise unsafe…

People newly diagnosed and receiving their initial care and follow-up at the Institut Bergonié during their treatment. Adolescents or young adults aged 15 to 39 who have been diagnosed with soft tissue or bone sarcoma, or a germ cell tumour (testicular or ovarian). Young women aged 15 to 49 who have been diagnosed…

People who have been diagnosed with advanced stage (Stage III or IV) ovarian, fallopian tube, or peritoneal cancer of a specific type (epithelial carcinoma or carcinosarcoma). A pathology report confirming the diagnosis of the original tumour is required. People whose cancer treatment plan includes chemotherapy given…

People who have been diagnosed with a specific type of ovarian, peritoneal, or fallopian tube cancer confirmed by laboratory tissue analysis — including high-grade serous, endometrioid, or carcinosarcoma (with at least 30% epithelial tumour component) types. People aged 18 years or older. People whose cancer is at an…

People who have been diagnosed with a likely or confirmed new or returning cancer tumour of any stage. People who are planned to receive chemotherapy or combined chemotherapy and radiation treatment before surgery (known as neoadjuvant treatment). People who have been assessed as suitable candidates for one of the…

People aged between 18 and 75 years old. People with a suspected or confirmed solid tumour, such as prostate cancer, liver cancer (hepatocellular carcinoma), ovarian cancer, or endometrial cancer. People who are already scheduled to have a tumour biopsy or surgery within the next 2 months. People who are generally…

People who are willing to take part voluntarily, sign a consent form, follow the treatment plan, and attend scheduled check-ups Women aged 18 or older (based on the date the consent form is signed) People who have been newly diagnosed — confirmed by laboratory testing of tissue — with high-grade serous ovarian cancer…

People who are willing and able to sign a written consent form agreeing to participate People who are at least 18 years old People who have been diagnosed with epithelial ovarian cancer, confirmed by laboratory testing of tissue or fluid samples People who have a BRCA1 or BRCA2 gene mutation, or whose cancer has…

People who are 18 years of age or older at the time of signing the consent form. People who have a confirmed diagnosis of endometrial cancer, epithelial ovarian cancer, peritoneal cancer, or fallopian tube cancer, based on tissue testing at a local lab. People who have received at least one previous course of…

Women aged 19 years or older who have been diagnosed with a specific type of ovarian cancer (high-grade serous, endometrioid, clear cell, or mixed type) confirmed by a pathology test. People whose cancer has been classified as an advanced stage (Stage III or IV). People who have completed surgery to remove tumours…

People who have been diagnosed (through laboratory testing of tissue or cell samples) with epithelial ovarian cancer, fallopian tube carcinoma, or primary peritoneal carcinoma at an advanced stage (FIGO 2014 stage III or IV). Female patients between 18 and 75 years of age. People who are willing and able to sign a…

People aged 18 to 80 years old. People who have been diagnosed through a tissue biopsy with advanced or returning high-grade cancer of the ovaries, fallopian tubes, or peritoneum (the lining of the abdomen). People whose cancer has come back or gotten worse after at least one prior chemotherapy treatment containing…

Women aged between 18 and 75 years (inclusive) at the time of signing the consent form. People who have been diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer confirmed by laboratory testing of tissue), at Stage II or Stage III according to an internationally recognised staging system (FIGO…

People with a specific type of ovarian, fallopian tube, or primary peritoneal cancer that is high-grade serous, has stopped responding to platinum-based chemotherapy, and has tested positive for a protein called folate receptor-alpha (meaning at least 75% of cancer cells show this protein at a moderate-to-strong…

The patient must be female and aged 18 years or older. The patient must have a laboratory-confirmed diagnosis of epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The patient's cancer must have gotten worse during or after their most recent cancer treatment. The patient's tumor must show…

People who are at least 18 years old and meet the legal age of consent where the study is taking place. People who have been newly diagnosed with Stage III or IV ovarian, primary peritoneal, or fallopian tube cancer, confirmed by tissue testing to be a specific type (high grade serous, high grade endometrioid, clear…

Women aged 18 or older at the time of signing the consent form. People who have been diagnosed through laboratory testing with a specific type of ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (high-grade serous carcinoma or grade 2–3 endometrioid carcinoma). People who have previously received…

People who fully understand the trial and are willing to sign a consent form voluntarily People aged 18 years or older People who have been confirmed by tissue or cell testing to have high-grade serous ovarian cancer, fallopian tube cancer, or primary peritoneal cancer People in Cohort A or B: those whose cancer…

People who have signed and dated a consent form agreeing to take part in the study. People who are willing to follow all study procedures and are available for the full duration of the study. Women aged 18 to 80 years. People who have been diagnosed with recurring epithelial ovarian cancer (all subtypes are eligible).…

Women aged between 18 and 75 years (inclusive) at the time of signing the consent form. People with a laboratory-confirmed diagnosis of epithelial ovarian cancer (a specific type of ovarian cancer that starts in the cells covering the ovary) that is classified as Stage II or Stage III according to an internationally…

People who are 18 years of age or older at the time of signing up, both male and female. People who can understand written and/or spoken English. People who are able to give informed consent to participate. People who have been diagnosed with cancer of any type. People who have either been recently diagnosed with…

You are between 18 and 80 years old You have at least one close family member (mother, sister, or daughter) who has had ovarian cancer, primary peritoneal cancer, or fallopian tube cancer You have at least two close or extended family members diagnosed before age 50 with ovarian, peritoneal, fallopian tube, and/or…

People who were originally diagnosed with a low-risk ovarian tumour (called a tumour of low malignant potential) whose disease has since progressed to a more aggressive form of cancer. People who were originally diagnosed with a low-grade serous carcinoma of the ovary whose disease has since progressed to a higher…

You are a woman aged 50 to 74 years old at the time of joining the trial You have gone through menopause, meaning you have had no periods for 12 months or more You still have at least one ovary You are currently cancer-free and have not had chemotherapy or radiation treatment in the past 12 months or more You are…

People who have been diagnosed with stage III or IV ovarian epithelial cancer (a specific type of ovarian cancer at an advanced stage) and were previously enrolled in certain Gynecologic Oncology Group (GOG) studies involving platinum and taxol chemotherapy treatments (confirm with trial site for which specific…

Women who have a high risk of developing breast or ovarian cancer because of a known inherited gene mutation (in BRCA1, BRCA2, PTEN, CDH1, or TP53), or because of a strong family history of breast or ovarian cancer even without a confirmed gene mutation Women who are scheduled for surgery to remove a mass in the…

People with measurable, metastatic cancer (cancer that has spread) of one of these types: upper or lower gastrointestinal, liver/bile duct, urinary/reproductive system, breast, ovarian/uterine, or hormone-related cancers including neuroendocrine tumours — and who have at least one tumour that a surgeon could safely…

You have been diagnosed with a type of tumor confirmed by a tissue sample (biopsy) called PPB (pleuropulmonary blastoma) and/or another tumor linked to a gene called DICER1 You have a known or suspected change (variant) in the DICER1 gene You have been diagnosed with one or more of a specific list of rare tumors that…

Adults between 18 and 90 years of age, of any gender People who currently have one known cancer diagnosis (and no other serious diseases) People who currently have one known inflammatory disease (and no other serious diseases)

You have been diagnosed (in the past or currently) with a type of ovarian tumor known as a "sex cord stromal tumor," which includes tumors such as Sertoli-Leydig cell tumor, juvenile granulosa cell tumor, Sertoli cell tumor, sex cord-stromal tumor with annular tubules, undifferentiated stromal tumor, or…

You have been diagnosed with cancer or have a history of cancer You are considered at risk of developing cancer, or you have some unusual findings that need further investigation You have no history of cancer and would be joining as a normal comparison participant You are able to understand and sign a consent form…

People who have a suspected or confirmed cancer of the upper reproductive tract (such as the uterus, fallopian tubes, or ovaries). People who are scheduled to have surgery to remove a tumour. People who are scheduled to have surgery to remove the uterus and both fallopian tubes, with or without removal of both…

Your breast cancer must test negative for estrogen receptors, progesterone receptors, and HER2 (a specific type called "triple negative") Your cancer can be at any stage (Stage I through Stage IV) You can be any age when you were diagnosed You must have been diagnosed within the last 5 years You can join whether or…

You are a Chinese woman aged 65 or younger You have been diagnosed with an ovarian stromal tumor (a specific type of ovarian tumor), confirmed by a tissue sample, including types such as granulosa cell tumor, Sertoli-Leydig cell tumor, or other related types (confirm with trial site for full list) Your cancer has been…

People who are 18 years of age or older People who have a known or suspected history of epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, whether newly diagnosed or recurring at the time of joining the study People who have at least one tumour or lesion measuring 1.0 cm or larger that is…

People who are older than 18 years of age. People who have a confirmed diagnosis of Triple Negative Breast Cancer that is either at an advanced (spread) stage and has not yet been treated with systemic (whole-body) therapy, or at an earlier stage with remaining tumour detected after completing chemotherapy containing…

People between 18 and 70 years of age People rated as ASA Class I, II, or III — this is a standard medical assessment of overall health before surgery, ranging from healthy to having some serious but manageable health conditions (confirm with trial site) People with colorectal (bowel) or gynaecological (female…

People who were diagnosed with borderline ovarian tumors, received treatment, and were monitored at medical institutions in South Korea between November 1994 and February 2015. People who have had gynaecological surgery for borderline ovarian tumors at medical institutions in South Korea from March 2015 onwards.

People who have been diagnosed with ovarian cancer

People who have been newly diagnosed with ovarian cancer, OR People who have been previously treated for ovarian cancer, whose cancer has come back, who have a stored tumour sample available from their original surgery, and who agree to have a biopsy of the returned cancer guided by a CT scan, OR People who have been…

You have been newly diagnosed with ovarian cancer and have not yet received any treatment, and you are a candidate for surgery or chemotherapy given before surgery. You have been newly diagnosed with triple-negative breast cancer and have not yet received any treatment, and you are a candidate for surgery or…

You have been diagnosed (confirmed by lab testing of tissue) with advanced ovarian cancer, primary peritoneal cancer, or fallopian tube cancer at a late stage (Stage III or IV). You have had either debulking surgery (to remove as much of the cancer as possible) or a diagnostic surgery within the 3 weeks before joining…

People who were diagnosed with cancer before age 26 and have at least one blood relative (within three degrees of relation) who was diagnosed with cancer before age 51. People who have had more than one cancer diagnosis, where at least one of those cancers was diagnosed before age 26. People who have been diagnosed…

People who carry a gene mutation linked to Hereditary Breast and Ovarian Cancer (HBOC) or Lynch Syndrome (LS) People who have at least one living blood relative Both men and women are eligible People aged 18 years or older People who are mentally and physically able to give their informed consent to participate People…

People who have given written informed consent before any study-related procedures begin. Women aged 20 years or older. People with a general health/activity level rated as 0, 1, or 2 on a standard oncology scale (meaning able to carry out at least some daily activities — confirm with trial site). People with a life…

People who are younger than 70 years old. People who have been diagnosed with a specific type of ovarian cancer (high grade serous carcinoma or low-grade endometrioid), confirmed by a tissue biopsy result. People whose cancer is at stage IIIC or stage IVA (where fluid around the lungs contains cancer cells), and who…

Women who carry a change (variant) in the BRCA1 or BRCA2 gene, including those with changes in both genes, or those with a gene change whose meaning is not yet fully understood (called a "variant of uncertain significance") Women who have already received genetic counseling at any medical facility before joining the…

People who have been diagnosed with, or are suspected to have, a type of lung tumour called pleuropulmonary blastoma (PPB) or a related chest tumour People who have been diagnosed with, or are suspected to have, certain tumours affecting the reproductive organs, including Sertoli-Leydig cell tumours and…

You have been diagnosed with a solid tumor cancer or a blood cancer (such as leukemia or lymphoma) Your cancer has been tested and shows one or more specific genetic changes, protein markers, or other biological features from a large list (including markers like PD-L1, BRCA1, BRCA2, EGFR, KRAS, HER2, and many others)…

People with a known or suspected solid tumour (a type of cancer that forms a lump or mass). People who have at least one tumour or lesion that is 1.0 cm or larger in size, visible on standard scans such as CT, MRI, ultrasound, or PET/CT imaging.

You are a woman or man aged 18 or older who carries a harmful change (mutation) in the BRCA1 or BRCA2 gene, whether or not you have cancer. You are a woman who may or may not have breast cancer or ovarian cancer at the time of joining the trial. You are a man who may or may not have breast cancer at the time of…

Your cancer diagnosis has been confirmed through a tissue or cell sample (biopsy or similar test). You are willing and able to sign a consent form agreeing to take part in the trial. You are over 18 years old and your doctors estimate you are likely to live for more than 3 months. Your liver is functioning at a…

People aged 18 or older who have been diagnosed with one of the following cancer types, confirmed by laboratory testing of tissue or cell samples: breast, stomach, kidney, prostate, lung (including both main types), liver, colorectal, head and neck, thyroid, pancreatic, ovarian, glioblastoma (a type of brain cancer)…

People aged 18 or older at the time of joining the trial. People with a confirmed diagnosis of platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, with a high-grade serous or predominantly serous/endometroid type — meaning the cancer came back or kept growing within 6 months of the…

People who have been diagnosed with, or are suspected of having, primary or returning ovarian cancer (a type of cancer affecting the ovaries and related areas), and who are scheduled for surgery, chemotherapy, and/or immunotherapy. People aged 18 or older. People who are reasonably well and able to carry out daily…

People who have signed a consent form agreeing to take part in the study. People aged 18 or older. People who have been diagnosed (confirmed by lab testing of tissue or cells) with a specific type of ovarian, fallopian tube, or peritoneal cancer — specifically high-grade serous or endometrioid type, or a cancer that…

Female patients of any ethnicity who are scheduled to have surgery to remove ovarian cancer tumours may be considered for this trial. Participants must be 18 years of age or older. There must be a medical suspicion or confirmed diagnosis of ovarian cancer, and surgery for tumour removal must already be planned.…

You must be 18 years old or older You must have been diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer) at any stage Your main surgery to remove the cancer must not have started yet, although pre-surgery chemotherapy is allowed Your treatment plan must include a chemotherapy type that…

People who have been diagnosed with a locally advanced or metastatic solid tumour (such as head and neck cancer, ovarian cancer, cervical cancer, glioblastoma, non-small cell lung cancer, anal cancer, or other solid tumour types), or people who have been diagnosed with high-grade pre-cancerous changes of the cervix…

People who have given written consent to participate before any study procedures begin People who have been confirmed by laboratory testing to have recurrent ovarian, fallopian tube, primary peritoneal, endometrial, vaginal, or cervical cancer located in the abdomen or pelvis People with cancer that has spread to…

People who are 18 years of age or older People who have recently been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer People for whom doctors have determined that at least one surgery and a course of chemotherapy are appropriate treatment options People who have given…

Adults between 18 and 75 years of age. People whose general health and ability to carry out daily activities falls within an acceptable range as measured by a standard oncology scoring system (confirm with trial site). People who have a type of ovarian, peritoneal, or fallopian tube cancer that came back after…

People who have been diagnosed with one of the following cancer types: kidney, bladder, or prostate cancer; melanoma or other skin cancers; lung cancer; head and neck cancer; sarcoma or lymphoma; cancers of the digestive system (including the gut, liver, bile ducts, or pancreas); gynaecological cancers (ovarian…

People who have been diagnosed with epithelial ovarian cancer, confirmed by a laboratory examination of tissue People whose cancer has been classified at a specific stage: FIGO Stage Ia or Ib (Grade 2 or 3, or a type called clear cell carcinoma), or FIGO Stage Ic(b) (any grade or type) (confirm with trial site if…

People who are 18 years of age or older People who are willing and able to attend all study visits and understand all study-related procedures People who have been newly diagnosed with a specific type of ovarian, fallopian tube, or peritoneal cancer (low or high grade serous or endometrioid type, Stage II to IV)…

Adults aged 18 or older who have been diagnosed with advanced or returning solid tumour cancer, where no other standard treatments are known to be helpful. People who are generally well enough to carry out light activity and care for themselves (measured by a standard health scale called ECOG, with a score of 0 or 1).…

People between 35 and 50 years old (inclusive) People who are planning to have both ovaries and fallopian tubes surgically removed to reduce cancer risk, OR people who have been fully counselled about that surgery but have chosen to delay or decline it and are instead having only their fallopian tubes removed for now…

People aged between 18 and 75 years old People diagnosed with a specific type of ovarian, fallopian tube, or peritoneal cancer called high-grade serous cancer, confirmed by biopsy or tissue testing People whose cancer was assessed by an initial keyhole surgery (laparoscopy) that confirmed the cancer type, how far it…

Women aged 70 or older, or women aged 60 or older who have significant other health conditions or difficulties with daily activities (confirm with trial site for exact scoring thresholds) People with a confirmed diagnosis of stage III or IV ovarian cancer, primary peritoneal cancer, or fallopian tube cancer, verified…

You have been diagnosed with a specific type of cancer that has spread or cannot be surgically removed, confirmed by a lab test — eligible cancer types include non-small cell lung cancer, head and neck squamous cell cancer, HER2-negative breast cancer, esophageal squamous cell carcinoma, esophageal/gastro-esophageal…

You have been diagnosed with ovarian cancer (including fallopian tube or primary peritoneal cancer) or endometrial (uterine) cancer, confirmed by a lab test on a tissue sample. For ovarian cancer: A specialist medical review panel has looked at your stored tumor tissue using standard genetic testing and found certain…

Women over the age of 50 years. Women over the age of 24 years who have a documented family history of ovarian cancer. Women over the age of 24 years who have a personal history of breast cancer. People with a general health status rated as fully active, restricted in strenuous activity, or capable of self-care but…

People who are 18 years of age or older People who may or may not have a cancer diagnosis People who received genetic counseling within the past 5 years People who have genetic variants in BRCA1, BRCA2, and/or Lynch syndrome genes Note: This group does not actively sign a consent form — records are reviewed under a…

You have been diagnosed with an advanced or spreading cancer that has been confirmed by a lab or pathology test Your cancer has either stopped responding to standard treatments, gotten worse after standard treatments, or you cannot tolerate the existing treatments available for your condition Your cancer can be…

Women aged 18 or older who have been confirmed by laboratory testing to have a specific type of ovarian, fallopian tube, or peritoneal cancer (not the low-grade or mucinous types) Women who are not pregnant, not breastfeeding, and either cannot become pregnant or agree to use contraception during treatment and for at…

Women between 18 and 75 years of age People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard medical scoring system called ECOG 0–2 (confirm with trial site) People who have been diagnosed through laboratory testing with a specific type of cancer —…

Women who have gone through menopause (either naturally, with no periods for 12 months, or due to surgical removal of the ovaries) People who have been diagnosed through a tissue or pathology test with stage III or IV ovarian cancer, fallopian tube cancer, or primary peritoneal cancer People whose general physical…

Women aged 18 or older at the time of signing the consent form. People who are planning to have surgery for one of the following cancers: high-grade serous ovarian cancer (Cohort A), breast cancer of a certain grade and size greater than 3 cm (Cohort B), or a widespread non-invasive breast cancer combined with a…

You are 18 years of age or older You have been diagnosed with a specific type of advanced ovarian, peritoneal, or fallopian tube cancer (stage IIIC or IV, high-grade type), or a similar related cancer type (confirm with trial site) Your doctor believes you are healthy enough to have surgery after completing 3 to 4…

You have a confirmed cancer that has spread or cannot be removed by surgery, and standard treatments no longer exist or are no longer working (dose escalation phase), OR you have confirmed high-grade serous ovarian cancer that has stopped responding to platinum-based chemotherapy (meaning the cancer progressed within…

You have been diagnosed with advanced ovarian cancer (not a type called carcinosarcoma), primary peritoneal cancer, or fallopian tube cancer, confirmed by a tissue or cell sample, and have already received at least one round of platinum-based chemotherapy (for ovarian cancer participants) You have been diagnosed with…

People who are at least 12 years old and have been diagnosed with a confirmed case of small cell carcinoma of the ovary (SCCOHT) that has not previously been treated (though joining after one cycle of chemotherapy may be possible, with treatment in the trial starting within 4 weeks of that first cycle). People whose…

People who have been diagnosed with high-grade serous epithelial ovarian cancer, confirmed by a biopsy People whose cancer is at stage III or IV and for whom doctors have determined that chemotherapy before surgery (neoadjuvant chemotherapy) is the appropriate treatment plan People whose tumor tests positive for a…

People who have been diagnosed with a confirmed recurrent form of epithelial ovarian cancer that has stopped responding to platinum-based chemotherapy (meaning the cancer came back or grew within 6 months of the last platinum chemotherapy dose). For the expansion phase of the trial only, people whose cancer is…

People who are able to understand the study procedures and are willing to sign a written consent form agreeing to take part. People who are able to follow the study schedule, including attending visits and following the treatment plan. People who are currently taking niraparib (either alone or with another treatment)…

People who have been diagnosed with suspected advanced-stage ovarian cancer that has not yet been treated, and who are planned to have a keyhole surgery (laparoscopy) to confirm the diagnosis and plan treatment People who are willing and able to follow the study schedule, including attending all planned visits and…

A person who has signed a consent form agreeing to take part in the study. A person whose previous cancer treatments ended at least 21 days ago (or a shorter period based on the specific drug used), and whose side effects from those treatments have mostly resolved. A person who has at least one area of cancer that can…

You have been diagnosed with a type of ovarian cancer called epithelial ovarian cancer. A camera examination of your large bowel (colonoscopy) showed no cancer involvement of the bowel's inner lining. During surgery, it was confirmed that the cancer has grown into the outer layers of a section of the bowel called the…

People who are 18 years of age or older at the time of signing the consent form People whose general health and ability to carry out daily activities is rated as fully active or restricted only in physically strenuous activity (this is measured using a standard oncology scoring scale called ECOG, with a score of 0 or…

You have a suspected or confirmed diagnosis of advanced ovarian, fallopian tube, or peritoneal cancer (stage III or IV, meaning the cancer has spread outside the pelvis). You are newly diagnosed (or suspected) and your doctor has recommended surgery to remove the cancer, but you have not had surgery yet. You are newly…

Women between 18 and 70 years old. Women who have been diagnosed with a specific type of ovarian cancer called epithelial ovarian cancer, at an early stage (FIGO stage IA–IIA), who either have not yet had treatment or had surgery that was not fully completed. Women whose cancer type and features mean they need…

People who agree and consent to take part in the study People aged 18 years or older, of any gender People who have been diagnosed with peritoneal carcinomatosis (cancer that has spread to the lining of the abdomen) originating from the digestive system or ovaries, and who are receiving care and treatment for this…

People aged 18 or older (based on self-report) People who currently have, or have previously had, breast, ovarian, pancreatic, or prostate cancer (based on self-report) People who identify as Black, Latino, or neither Black nor Latino People who speak and read English, Haitian Creole, or Spanish at a "well" or "very…

People who are willing and able to sign a written consent form agreeing to take part in the trial. People who are 18 years of age or older at the time of signing the consent form. People who have been diagnosed with an advanced cancer confirmed through laboratory testing of a tissue sample. People who are unable to…

People who have been diagnosed (confirmed by tissue testing) with advanced, spreading, or returning ovarian cancer, primary peritoneal cancer, or fallopian tube cancer that cannot be cured. People whose cancer came back or got worse within six months of finishing a platinum-based chemotherapy treatment (this is called…

You have ovarian cancer (epithelial type) at an advanced stage (Stage III or IV), and your doctors have decided surgery is not the right first step — instead, you are due to have chemotherapy first, followed by surgery later You have uterine (endometrial) cancer at an early stage (Stage I or II), your doctors have…

You still have your uterus and have not had uterine ablation, tubal ligation, or both fallopian tubes removed Group 1: Women who are scheduled for surgery or a keyhole diagnostic procedure because doctors suspect (but have not yet confirmed) ovarian or fallopian tube cancer Group 2: Women who are known carriers of a…

Adults aged 18 or older at the time of signing consent forms People diagnosed with a non-seminoma germ cell tumour, confirmed through tissue biopsy or blood tests People whose cancer came back after initial treatment with cisplatin-based chemotherapy People who have completed two cycles of high-dose chemotherapy with…

People aged between 18 and 75 years old People with a general health status that allows them to carry out daily activities, either fully or with some limitations (confirm with trial site what level of functioning is required) People who have been diagnosed with a specific type of cancer — confirmed by lab testing —…

People who are 18 years of age or older at the time they sign the consent form People who have been newly diagnosed with a confirmed advanced-stage ovarian, fallopian tube, or peritoneal cancer (specifically FIGO stage III or IV, high-grade serous or high-grade endometrioid type) People who have had primary or…

You are a patient at Turku University Hospital who is suspected of having ovarian cancer. You are able to understand the study information and are willing to sign a consent form agreeing to take part.

For Part A: You must be at least 12 months old and no older than 21 years old when you join the study; for Part B, you must be at least 12 months old and no older than 30 years old. You have a solid tumor (including certain types of lymphoma called non-Hodgkin lymphoma, or a type of tumor called a desmoid tumor) that…

People who are 18 years of age or older People who have been diagnosed with primary or recurring ovarian cancer, fallopian tube cancer, or primary peritoneal cancer People who are scheduled to have debulking or cytoreductive surgery (surgery to remove as much of the tumour as possible) People where the surgical team…

Women who have been diagnosed with high grade serous ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum-based chemotherapy (meaning the cancer got worse within 6 months of the last platinum chemotherapy). People whose cancer can be measured on scans or physical examination, meeting…

Adults aged 18 or older at the time of signing the consent form People with recurrent (returned) epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer of certain types, or people with cancer affecting both the ovary and uterus at the same time — regardless of how the cancer responded to…

People who are willing and able to sign a written consent form agreeing to take part in the study. Women aged 18 to 70 years old. People who have been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed by a tissue or cell sample. People whose cancer has stopped responding to…

People who are 18 years of age or older. People (or their legal representative) who are able to give written agreement to take part before any study procedures begin. Group A: Kidney cancer (that has spread or cannot be removed) after trying at least two prior treatments including a targeted therapy and an…

People who have been fully informed about the study and have signed a consent form agreeing to take part. Adults aged 18 or older. In the earlier phase (Phase 1a): people with advanced or spreading salivary gland, bladder, ovarian, or breast cancer whose cancer has grown or returned after standard treatment, or who…

You have been recently diagnosed with stage III or IV ovarian or endometrial cancer You are receiving your first round of chemotherapy (carboplatin and paclitaxel) after surgery You are 18 years of age or older Your doctor has confirmed it is safe for you to do moderate to vigorous exercise You are able to read…

People who have already received at least one systemic (whole-body) treatment for advanced, inoperable, or metastatic cancer — or whose treating doctor considers there are no standard treatments that would provide meaningful benefit, or who cannot tolerate or have declined standard treatments. People with an activity…

People who have signed a consent form showing they understand and agree to take part in the trial before any trial procedures begin. Women aged 18 or older who have been diagnosed through a tissue biopsy with a specific type of advanced ovarian, peritoneal, or fallopian tube cancer (high grade, non-mucinous, non-clear…

People who have ovarian cancer, at any stage or grade People who have fluid build-up in the abdomen (called ascites) that needs to be drained People on any type of cancer treatment plan People experiencing ascites for the first time or as a returning condition People who understand what the study involves and are…

You have been recently diagnosed with ovarian cancer for the first time and have started treatment Your cancer has been confirmed by a tissue sample (biopsy) to be a type that starts in the cells lining the ovaries, fallopian tubes, or the lining of the abdomen (called epithelial cancer) Your cancer is at stage II…

Women aged 18 or older People who have been diagnosed with ovarian cancer, confirmed through a laboratory tissue analysis People who had surgery in the gynaecology department at Strasbourg University Hospital between 2021 and 2024 People who have agreed to take part in the trial and to have biological samples…

Adults aged 18 or older who are willing and able to give written consent to participate. People with advanced solid tumours that have been confirmed by laboratory testing of tissue or cell samples, including specific tumour types depending on which part of the trial is relevant (confirm with trial site for which…

This trial has multiple groups (called cohorts). Each group has its own criteria. People aged 45 or older who have abnormal uterine bleeding or bleeding after menopause People aged 18 to 44 who have abnormal uterine bleeding AND at least one of the following: a BMI of 30 or higher, a condition called polycystic ovary…

You are 18 years of age or older You are well enough to carry out some normal daily activities (your doctor can confirm this using a standard health scoring tool) You are expected to live for more than six months You are able to speak English For the Head & Neck, Thoracic, Gynecologic, Melanoma, and Breast group: You…

People who are over 18 years old People whose cancer treatment is being given with the goal of curing or removing the cancer completely People who are planning to have regular check-ups to monitor for cancer coming back, as part of their normal care at the enrolling hospital or clinic People who are willing to sign a…

You are a woman aged 18 or older You are reasonably well and able to carry out daily activities (your doctor will assess this using a standard scale) You have been diagnosed with a specific type of ovarian, fallopian tube, or peritoneal cancer (high grade serous or high grade endometrioid), confirmed by a tissue…

People who are 18 years of age or older People at U.S. trial sites who can read and understand English or Spanish, or at Canadian sites who can read and understand English or French People who have been confirmed or are suspected to have a specific type of cancer affecting the ovaries, fallopian tubes, or the lining…

People who have been diagnosed with non-small cell lung cancer (NSCLC), ovarian cancer, or prostate cancer that has spread or cannot be removed with surgery, confirmed by laboratory testing of tissue samples. People who have already received at least one approved cancer treatment, and either have no remaining standard…

People who have been diagnosed with recurrent primary mucinous ovarian cancer, confirmed through laboratory testing of a tissue or cell sample People aged 18 or older People who are reasonably able to carry out daily activities (assessed using a standard health scale, confirm with trial site) People whose blood counts…

You have been diagnosed with high-grade ovarian, fallopian tube, or primary peritoneal cancer at an advanced or widespread stage (stage IIb or higher), and you are about to start a new course of treatment. Your ovarian, fallopian tube, or primary peritoneal cancer has come back after previous treatment, and you are…

People who identify as a Latina woman People who are 18 years of age or older People who are able to give informed consent to participate People who are fluent in Spanish People whose personal or family history of cancer meets national guidelines (NCCN criteria) for being considered for genetic cancer risk assessment…

You must be at least 18 years old You must either be going through tests for a condition that could potentially become cancer, be monitored for such a condition, or already have a cancer diagnosis You must be willing to read, sign, and understand the consent form before taking part in the study

Women aged 18 or older with a newly diagnosed cancer of the ovary, fallopian tube, or peritoneum (the lining of the abdomen). People whose cancer type has been confirmed by a tissue sample as high-grade serous, high-grade endometrioid (grade 2 or 3), or another non-mucinous, non-clear cell epithelial ovarian cancer —…

Women aged 18 years or older People with a confirmed diagnosis of stage IIIC or stage IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal carcinoma People whose scans (CT or PET/CT) show a low, medium, or high tumour spread, but with a specific spread score of 12 or below People whose scans…

People who are willing to sign a consent form and voluntarily take part in the study People who have been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed through a tissue or cell sample test People who are 18 years of age or older People whose doctor determines…

Your own blood cells have already been checked and confirmed suitable for making a special type of immune cell treatment (T-cells) You are willing and able to sign a consent form agreeing to take part and allow your health information to be used You are able to carry out basic daily activities, based on a standard…

You must be able to understand and willing to sign a written consent form to participate. You must agree to allow researchers to use stored tissue samples from a previous tumor biopsy (exceptions may be possible with approval). You must be 18 years of age or older. You must be well enough to carry out daily…

People who have given documented, informed consent to take part in the study. People who are willing to allow the study team to access and use existing stored tissue samples, if those samples are available. People aged 18 or older. People whose general physical functioning is rated at a level where they are able to…

You are between 18 and 75 years old You have been diagnosed with stage III or IV ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has been confirmed by a pathology test, OR you have one of these cancers that has come back and is still responding to platinum-based chemotherapy (after no more…

You are a woman between 18 and 80 years old You have had a type of internal radiation treatment called brachytherapy You have been diagnosed with a gynecological cancer (a cancer affecting the female reproductive system)

You are female and 18 years of age or older You have been diagnosed with ovarian cancer, confirmed by both imaging scans and tissue testing (pathology) You have not received any anti-cancer drug treatment before your surgery at Sun Yat Sen Memorial Hospital of Sun Yat-Sen University You have had surgery for ovarian…

Women aged 18 or older who have given written consent to take part before any study procedures begin. People diagnosed with a specific type of ovarian, fallopian tube, or primary peritoneal cancer (high-grade serous or endometrioid) that has come back or gotten worse after a first course of PARP inhibitor (PARPi)…

You have been diagnosed with ovarian, fallopian tube, or primary peritoneal cancer that cannot be surgically removed, confirmed by a tissue biopsy from a previous treatment. Your cancer is one of these specific types: high-grade serous, endometrioid, or clear-cell ovarian cancer (certain mixed tumors may also qualify…

You have agreed to take part and signed a consent form. You are 18 years of age or older. You have been diagnosed with ovarian, fallopian tube, or peritoneal cancer (or abdominal cancer that appears to have started in one of these areas). Your cancer type is specifically high grade serous carcinoma, endometrioid…

Women who have not yet reached menopause and have a confirmed harmful gene mutation in one or more of the following genes: BRCA1, BRCA2, BRIP1, RAD51C, PALB2, or RAD51D. Women aged 25–40 if they carry a BRCA1 mutation, aged 25–45 if they carry a BRCA2 mutation, or aged 30–50 if they carry a BRIP1, RAD51C, RAD51D, or…

People aged 18 or older who are able to give informed consent to participate. People who have been diagnosed with a specific type of ovarian, primary peritoneal, or fallopian tube cancer that has been confirmed by a pathology test, including certain grades and types such as serous, endometrioid, clear cell, mucinous…

People who have been diagnosed (confirmed by lab testing of tissue or cells) with one of these advanced cancers that cannot be removed by surgery with the aim of a cure: triple-negative breast cancer (TNBC), head and neck squamous cell cancer (of the mouth, throat, voice box, or related areas), high-grade ovarian…

You have been diagnosed with an invasive cancer that has been confirmed by a tissue sample (biopsy), or you are strongly suspected of having certain cancers (ovarian, pancreatic, kidney, or melanoma) with a confirmed diagnosis expected within 28 days Your cancer is one of the following types: colorectal, bladder, head…

You are 18 years of age or older You have been officially diagnosed with stage III or IV ovarian cancer You are planning to have surgery to remove tumors as part of your cancer treatment Your surgery is scheduled at least 4 weeks after you would enroll in the study You are able to attend exercise sessions either in…

You have been newly diagnosed with cancer within the last 120 days, or have had a cancer come back after being cancer-free for more than 5 years, and your cancer is one of these types: Brain, Breast, Bladder, Cervical, Colorectal, Endometrial, Esophageal, Stomach, Head and Neck, Liver/Bile Duct, Lung, Ovarian…

People who have a solid tumour (a type of cancer that forms a lump) that has come back or spread to other parts of the body People who are well enough to carry out normal daily activities with little or no limitation (measured by a standard health scale called ECOG, scores 0 or 1) People in a specific part of the…

People aged between 18 and 60 years old People who have ovarian cancer that has been confirmed through laboratory testing of tissue samples (histopathology) People whose ovarian cancer has come back or spread to other parts of the body People whose ovarian cancer has been assessed as needing chemotherapy treatment…

You have been diagnosed with advanced (stage II–IV) ovarian, fallopian tube, or peritoneal cancer, based on scans, a blood test called CA125, and a doctor's assessment You are scheduled to have open abdominal (exploratory) surgery to remove as much of the cancer as possible Your surgery is planned at least 10 days…

You have been recently diagnosed with ovarian cancer, fallopian tube cancer, or a related cancer that has spread to the lining of the abdomen, and you are planning to have surgery to remove the tumors (either as a first surgery or after receiving chemotherapy first) Scans before surgery suggest the cancer may have…

People who have been diagnosed with epithelial ovarian cancer confirmed by a pathology test People who have already completed standard first-line treatment for their ovarian cancer, which for advanced cases includes surgery to remove as much of the tumour as possible, followed by platinum-based chemotherapy People who…

The person must give written consent to take part before any trial-related procedures begin. The person must be a woman aged 18 or older. The person must have been diagnosed with Stage III or Stage IV high-grade ovarian cancer (all tissue types except mucinous). The person must have had surgery that removed all…

People aged 18 or older People who receive care at Massachusetts General Hospital or Boston Medical Center People who have been diagnosed with malignant epithelial ovarian cancer or malignant pancreatic adenocarcinoma (a type of pancreatic cancer)

Women aged 18 or older. People with a confirmed diagnosis of certain gynaecological cancers (including endometrioid cancer, mucinous ovarian cancer, high-grade serous ovarian cancer, or other solid gynaecological cancers) that have specific genetic changes — mutations in RAS, BRAF (type I, II, or III), loss of NF-1…

A person must sign a consent form agreeing to take part in the study The treating doctor must judge that the person is able to follow the study procedures A person must have been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed through laboratory testing of…

You have ovarian cancer with a specific type (low or high grade serous carcinoma, or endometrioid carcinoma), and you have already had 1 to 3 rounds of platinum-based chemotherapy after your initial surgery. You have at least one tumor that can be measured on a scan. It has been more than 6 months since your last…

You are willing and able to give written consent to take part in the study. You are a woman aged 18 or older at the time of signing the consent form. You have been diagnosed (confirmed by tissue testing) with high-grade serous carcinoma of the ovary, fallopian tube, or peritoneum (the lining of the abdomen). Your…

You have cancer that can be measured (for example, by scans or tests) You are physically able to carry out basic daily activities, at a level that meets one of the standard health scoring systems used in cancer care (your doctor will assess this) Your doctor believes you may be a good fit for one of the related…

You have been diagnosed (confirmed by lab/pathology results) with one of these cancers that has come back or gotten worse: advanced ovarian cancer, primary peritoneal cancer, fallopian tube cancer, bile duct cancer (cholangiocarcinoma), or mesothelioma (affecting the lining of the lungs or abdomen) You have already…

You have been recently diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer) that has been confirmed by a tissue test (biopsy) If your cancer is at an early stage (Stage I or II), you have a known change (mutation) in the BRCA1 or BRCA2 gene, either inherited or found in the tumor itself If your…

You are between 20 and 80 years old You are in generally good to moderate overall health (confirm with trial site) You are scheduled for a planned brain surgery (craniotomy) for a primary ovarian tumor under general anesthesia

People diagnosed with recurrent epithelial ovarian cancer, peritoneal cancer, or fallopian tube cancer that is being treated for the first or second time it has come back, who previously received at least 4 cycles of platinum-based chemotherapy as their initial treatment People whose cancer came back more than 6…

You are a woman aged 18 or older with ovarian, fallopian tube, or primary peritoneal cancer that has come back after previous treatment Your cancer has been confirmed by a pathologist as one of these specific types: high grade or low grade papillary serous, high grade or low grade mucinous, clear cell, or high grade…

People aged 18 or older at the time of joining the study. People who are willing and able to follow the study schedule, including attending appointments and completing follow-up visits, for the full duration of the trial. People who have been diagnosed (confirmed by laboratory tissue testing) with ovarian cancer…

People who are currently taking long-term targeted cancer treatment medications

Women who are scheduled for a mammography screening at a Project VALET mobile screening unit may be eligible.

People who have been diagnosed with a specific type of ovarian, fallopian tube, or primary peritoneal cancer (high grade serous or endometrioid type) that has reached an advanced stage (FIGO stage III or IV), confirmed by CT scan or MRI. People who have been recommended to receive platinum-based chemotherapy before…

People who have been diagnosed through laboratory testing with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (but not the mucinous type). People whose cancer has come back or stopped responding to treatment, and who have already tried at least one standard chemotherapy plan that…

You have been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has come back for the first time Your cancer is the type that grows from the lining of the organs (called epithelial), at any original stage Your cancer came back at least 6 months after you finished your last…

You have been diagnosed with ovarian cancer, fallopian tube cancer, or peritoneal cancer (confirmed by a tissue or fluid sample), and it is classified as stage III or stage IV Your general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard scoring system (score…

People diagnosed with ovarian, fallopian tube, or primary peritoneal cancer with a specific type called high-grade serous adenocarcinoma (including poorly differentiated carcinomas consistent with this type), confirmed through tissue biopsy or surgery (not fluid samples alone) People whose cancer has been classified…

You are 18 years of age or older You have been diagnosed with an advanced or spreading solid tumour (such as colorectal cancer, triple-negative breast cancer, melanoma, or ovarian cancer) that cannot be surgically removed, and your cancer has continued to grow despite standard treatments, you cannot tolerate standard…

People aged 18 to 70 years old who are female. People who have been diagnosed through laboratory testing (tissue or cell analysis) with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, where the cancer came back within less than 6 months after completing a platinum-based chemotherapy…